Tocilizumab Fails Late-Stage Trial for COVID-19
Denosumab Dosing Delays Tied to Increased Fracture Risk
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis
Ixekizumab May Improve Pain & Sexual Health in Patients with Genital Psoriasis
FDA Approves Canakinumab for Adult-Onset Still’s Disease
Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients
Biologic Treatment Recommendations for Rheumatic Disease Patients Who Contract COVID-19
Apremilast Promising for Plaque Psoriasis
Biosimilar Prescribing Habits in the VA & Academic Settings
- 1
- 2
- 3
- …
- 105
- Next Page »